G2GBio Inc
KOSDAQ:456160
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
G2GBio Inc
KOSDAQ:456160
|
KR |
|
Nippon Chemi-Con Corp
TSE:6997
|
JP |
|
Oncimmune Holdings PLC
F:OCY
|
UK |
|
M
|
Media Nusantara Citra Tbk PT
XBER:5M2
|
ID |
|
Fruition venture Ltd
BSE:538568
|
IN |
|
T
|
theglobe.com Inc
OTC:TGLO
|
US |
|
Godolphin Resources Ltd
ASX:GRL
|
AU |
|
Agro-Kanesho Co Ltd
TSE:4955
|
JP |
|
Versus Systems Inc
NASDAQ:VS
|
CA |
|
Q
|
Qualitas Semiconductor Co Ltd
KOSDAQ:432720
|
KR |
|
Alchemist Corporation Ltd
BSE:531409
|
IN |
|
O
|
OrganoidSciences Ltd
KOSDAQ:476040
|
KR |
Bankruptcy Probability
G2GBio Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
G2GBio Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
G
|
G2GBio Inc
KOSDAQ:456160
|
618.8B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
G2GBio Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, G2GBio Inc has total debt of 1.7B KRW. This includes both short-term (0 KRW) and long-term (1.7B KRW) debt.
You can find a full breakdown on its Balance Sheet.
